Human Papillomavirus (HPV) Vaccine Market Forecast to 2028

Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and Distribution Channel (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)

Publication Month: Jun 2022 | Report Code: TIPRE00029411 | No. of Pages: 277 | Category: Pharmaceuticals | Status: Published

The human papillomavirus (HPV) vaccine market was valued at US$ 4,273.84 million in 2022 and is projected to reach US$ 5,730.50 million by 2028; it is expected to grow at a CAGR of 5.0% from 2022 to 2028.

Human papillomaviruses (HPV) is a diverse group of DNA-based viruses that infect the mucous and skin membranes of humans and various animals. More than 100 different types of HPV have been characterized. The increasing prevalence of various cancers caused by HPV is expected to drive the human papillomavirus (HPV) vaccine market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), HPV is the most common sexually transmitted infection in the US. Over 60% of penile cancers, 70% of vulvar and vaginal cancers, and 90% of anal and cervical cancers are caused due to HPV infection. CDC also states that about 14 million people are newly infected by the virus every year in the US.

Strategic Insights

The global human papillomavirus (HPV) vaccine market is segmented on the basis of type, dosage, age, distribution channel, and geography. The market, by region, is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the human papillomavirus (HPV) vaccine market, emphasizing on various parameters such as market trends, technological advancements, and market dynamics. It also includes the competitive landscape analysis of leading market players across the globe.

Lucrative Regions for Human Papillomavirus (HPV) Vaccine Market

Lucrative Regions for Human Papillomavirus (HPV) Vaccine Market

Get more information on this report :


Market Insight
Increase in Prevalence of HPV Associated Diseases

Human papillomavirus (HPV) is a common sexually transmitted infection and can cause cervical, oropharyngeal cancer, and cancer of the vagina, vulva, penis, or anus. It also causes various diseases, such as anogenital warts and recurrent respiratory papillomatosis. HPVs have also been detected in lichen sclerosus, skin tags, seborrheic keratoses, epidermal cysts, actinic keratoses, and psoriatic plaques. A significant burden of HPV-associated diseases is likely to drive the market's growth.

In women, cervical cancer is the fourth most common cancer. As per the World Health Organization (WHO) report estimation, in 2018, an estimated 570,000 women worldwide had cervical cancer, and about 311,000 female deaths were due to cervical cancer. Additionally, the American Society of Clinical Oncology (ASCO) estimated that around 14,100 cases of invasive cervical cancer would be registered in the US alone. Further, as per the report, 'Cervical cancer burden in EU-27,' in 2020, there were 30,447 new cases and 13,437 deaths due to cervical cancer in women.

Further, as per the Centers for Disease Control and Prevention (CDC), in 2018, there were around 43 million HPV infections in the US. The CDC also estimated that about 19,400 women and 12,100 men annually suffer from cancers caused by HPV. Further, as per the National Foundation for Infectious Diseases (NFID), there are around 14 million new HPV infection cases in the US every year. In addition, as per the report, titled 'Human Papillomavirus and Related Diseases Report-Europe,' in 2020, 8,449 women and 4,327 men had anal cancer in Europe.

Such a high incidence of HPV associated infections across the world is likely to favor the overall market growth in the coming years.

Type-Based Insights


Based on type, the human papillomavirus (HPV) vaccine market is segmented into 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. In 2022, the quadrivalent HPV vaccine segment holds the largest market share. However, the market for the 9-valent HPV vaccine segment is expected to witness the rapid growth from 2022 to 2028. The quadrivalent human papillomavirus (HPV) vaccine protects against infection with HPV types 6, 11, 16, and 18, which are responsible for 70% to 80% of cervical cancers and at least 90% of genital warts cases. The vaccine reduces the risk of genital warts and the precursor lesions of cervical, vaginal, and vulvar cancers caused by the virus.

Global Human Papillomavirus (HPV) Vaccine Market, by Application – 2022 and 2028

Global Human Papillomavirus (HPV) Vaccine Market, by Application – 2022 and 2028

Get more information on this report :


Dosage-Based Insights

Based on dosage, the human papillomavirus (HPV) vaccine market is segmented into 2 dose and 3 dose. In 2022, the 2 dose segment accounts for a larger market share.

Age-Based Insights

The global human papillomavirus (HPV) vaccine market, based on age, is segmented into 9 to 14 years and 15 to 45 years. The 9 to 14 years segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during the forecast period.

Application–Based Insights

In terms of application, the global human papillomavirus (HPV) vaccine market is segmented into HPV-attributable cancers and genital warts. The HPV-attributable cancers segment holds a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during the forecast period.

Distribution Channel–Based Insights

On the basis of distribution channel, the global human papillomavirus (HPV) vaccine market is segmented into doctors office, community health clinics, school-based health centers, health departments, hospitals, and others. The hospitals segment holds the largest share of the market in 2022, and the school-based health centers segment is anticipated to register the highest CAGR in the market during the forecast period.

The COVID-19 pandemic is likely to have longer-term consequences on the HPV vaccine business. Many primary care clinics in the US have continued to operate at a reduced capacity to abide by social distancing measures and adopt stringent cleaning protocols. A reduction in in-person office visits limits opportunities for vaccine providers to discuss and deliver vaccines. Barriers in transportation are likely to harm HPV vaccination; pharma and biotech companies traditionally find it difficult to market vaccines among the masses because of resistance received from parents and the absence of widespread awareness about school entry requirements that support other adolescent vaccines. The available evidence indicates that the COVID-19 pandemic has dramatically disrupted the delivery of HPV vaccines in 2020 and 2021. Early reports by CDC, suggest that ordering and billing dropped by >70% in March 2020. Furthermore, a 25–50% decrease in HPV vaccine orders continued in June 2020, in contrast to other early childhood-vaccine orders that resurged to near pre-pandemic levels. Although the revival of the HPV vaccine market is in progress, available data suggest that a short-term decline in HPV vaccination coverage will be substantial, and the demand for HPV vaccine will grow across North America in long term.

Companies commonly adopt product launches and expansion strategies to expand their footprint worldwide, meet the growing demand, and expand their product portfolio. The players operating in the global human papillomavirus (HPV) vaccine market implement the strategy of product innovation for changing customer demand worldwide, which also permits them to maintain their brand name globally.

  • In May 2022, China’s National Medical Products Administration (NMPA) approved GlaxoSmithKline’s (GSK) two-dose vaccine schedule, Cervarix, in girls from 9 to 14 years to prevent cervical cancer. Cervarix is a recombinant, noninfectious, AS04-adjuvanted HPV bivalent (types 16, 18) vaccine.
  • n May 2022, Serum Institute of India announced the development of a tetravalent HPV vaccine including L1 VLPs of serotypes 6,11,16,18, which is expected to give a coverage of ~90% against papillomavirus. The vaccine is currently under development.
  • In May 2020, Shanghai Bovax Biotechnology collaborated with Chongoing Bovax Biopharmaceutical to evaluate the immunogenicity and safety of 4-valent and 9-valent HPV recombinant vaccines.

By geography, the human papillomavirus (HPV) vaccine market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, Russia, Belarus, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, Southeast Asia, New Zealand, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, Iran, Turkey, Kuwait, Bahrain, Egypt, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, Chile, Guatemala, Peru, Colombia, and the Rest of South & Central America). GSK; Innovax; Walvax; Serum Institute of India Pvt., Ltd.; Vaccitech; Innovio Pharmaceuticals; Merck & Co., Inc.; 2A Pharm; ChengDu Institute of Biological Products Co., Ltd.; Sanofi; R-Pharm; Shanghai Bowei; and BioLeaders are among the leading companies operating in the market.

Frequently Asked Questions

Human papillomaviruses is a diverse group of DNA-based viruses that infect the mucous and skin membranes of humans and various animals. More than 100 different types of human papillomavirus have been characterized. Increasing prevalence of various cancers caused by human papillomavirus is expected to drive the market during the forecast period. According to the Centers for Disease Control and Prevention (CDC), human papillomavirus is the most common sexually transmitted infection in the U.S. Over 60% of penile cancers, 70% of vulvar and vaginal cancers, and 90% of anal and cervical cancers are caused due to human papillomavirus infection. CDC also states that about 14 million people are newly infected by human papillomavirus every year in the U.S.
Driving factor such as increase in prevalence of HPV associated diseases and initiatives taken by global health organizations are likely to have a positive impact on the growth of the global human papillomavirus (HPV) vaccines market. Whereas factors, such as growing number of HPV awareness programs, are likely to create a growth opportunity on the HPV vaccines market in the near future.
The human papillomavirus vaccine market majorly consists of the players such Merck & Co. In., GSK, Serum Institute of India, Walvax Biotechnologies, Innovax, Vaccitech, Innovio Pharmaceuticals, Chengdu Institute of Biological Products Co., Ltd., Sanofi, R-Pharm, Shanghai Bowei, and Bioleaders amongst others.
The human papillomavirus vaccine market, by type, is bifurcated 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. In 2022, the quadrivalent HPV vaccine segment held the largest share of the market, by type. However, the 9-valent HPV vaccine segment is expected to witness the fastest growth during 2022 to 2028.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Human Papillomavirus (HPV) Vaccines Market – By Type

1.3.2 Global Human Papillomavirus (HPV) Vaccines Market – By Dosage

1.3.3 Global Human Papillomavirus (HPV) Vaccines Market – By Age

1.3.4 Global Human Papillomavirus (HPV) Vaccines Market – By Application

1.3.5 Global Human Papillomavirus (HPV) Vaccines Market – By Distribution Channel

1.3.6 Global Human Papillomavirus (HPV) Vaccines Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Human Papillomavirus (HPV) Vaccine Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East and Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Human Papillomavirus (HPV) Vaccine Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of HPV Associated Diseases

5.1.2 Initiatives Taken by Global Health Organizations

5.2 Market Restraints

5.2.1 High Cost of HPV Vaccines

5.3 Market Opportunities

5.3.1 Growing Number of HPV Awareness Programs

5.4 Future Trends

5.4.1 Advancements in HPV Diagnostics Tests

5.5 Impact Analysis

6. Human Papillomavirus (HPV) Vaccine Market– Global Analysis

6.1 Global Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis

6.2 Global Human Papillomavirus (HPV) Vaccine Market, By Geography - Forecast and Analysis

6.3 Global Human Papillomavirus (HPV) Vaccine Market – Market Potential Analysis, By Region

6.4 Global Human Papillomavirus (HPV) Vaccine Market – Pricing Analysis, By Region

6.5 Global Human Papillomavirus (HPV) Vaccine Market – Patent Status

6.6 Growth Strategy Analysis

6.7 Performance of Key Players

6.7.1 Merck & Co., In.

6.7.2 GSK

7. Global Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast To 2028– by Type

7.1 Overview

7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)

7.3 9-valent HPV vaccine

7.3.1 Overview

7.3.2 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

7.4 Quadrivalent HPV vaccine

7.4.1 Overview

7.4.2 Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

7.5 Bivalent HPV Vaccine

7.5.1 Overview

7.5.2 Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)

8. Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 by Dosage

8.1 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)

8.2 2 Dose

8.2.1 Overview

8.2.2 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

8.3 3 Dose

8.3.1 Overview

8.3.2 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9. Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 by Age

9.1 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)

9.2 9 to 14 Years

9.2.1 Overview

9.2.2 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9.3 to 45 Years

9.3.1 Overview

9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

10. Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 by Application

10.1 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)

10.2 HPV-attributable Cancer

10.2.1 Overview

10.2.2 HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

10.3 Genital Warts

10.3.1 Overview

10.3.2 Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

11. Global Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 – by End User

11.1 Overview

11.2 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)

11.3 Doctor Office

11.3.1 Overview

11.3.2 Doctor Office Market Revenue and Forecast to 2028 (US$ Million)

11.4 Community Health Clinics

11.4.1 Overview

11.4.2 Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)

11.5 School-based Health Centers

11.5.1 Overview

11.5.2 School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)

11.6 Health Departments

11.6.1 Overview

11.6.2 Health Departments Market Revenue and Forecast to 2028 (US$ Million)

11.7 Hospitals

11.7.1 Overview

11.7.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)

11.8 Others

11.8.1 Overview

11.8.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 Geographical Analysis

12.1 North America: Human Papillomavirus (HPV) Vaccine Market

12.1.1 Overview

12.1.2 North America: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3 North America: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.4 North America: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.5 North America: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.6 North America: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.7 North America: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.1.8 North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

12.1.8.1 US: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.1 Overview

12.1.8.1.2 US: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.3 US: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.8.1.4 US: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.8.1.5 US: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.8.1.6 US: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.8.1.7 US: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.1.8.2 Canada: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.1 Overview

12.1.8.2.2 Canada: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.3 Canada: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.8.2.4 Canada: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.8.2.5 Canada: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.8.2.6 Canada: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.8.2.7 Canada: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.1.8.3 Mexico: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.1 Overview

12.1.8.3.2 Mexico: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.3 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.1.8.3.4 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.1.8.3.5 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.1.8.3.6 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.1.8.3.7 Mexico: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.2 Europe: Human Papillomavirus (HPV) Vaccine Market

12.2.1 Overview

12.2.2 Europe: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3 Europe: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.4 Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.5 Europe: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.6 Europe: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.7 Europe: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8 Europe: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

12.2.8.1 Germany: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.1 Germany: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.2 Germany: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.3 Germany: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.4 Germany: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.5 Germany: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.6 Germany: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2 France: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.1 France: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.2 France: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.3 France: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.4 France: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.5 France: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.6 France: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3 UK: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.1 UK: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.2 UK: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.3 UK: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.4 UK: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.5 UK: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.6 UK: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4 Italy: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.1 Italy: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.2 Italy: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.3 Italy: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.4 Italy: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.5 Italy: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.6 Italy: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5 Spain: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.1 Spain: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.2 Spain: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.3 Spain: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.4 Spain: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.5 Spain: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.6 Spain: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6 Russia: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.1 Russia: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.2 Russia: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.3 Russia: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.4 Russia: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.5 Russia: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.6 Russia: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.7 Belarus: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.7.1 Belarus: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.7.2 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.7.3 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.7.4 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.7.5 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.7.6 Belarus: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.8 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.8.1 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.8.2 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.8.3 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

12.2.8.8.4 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

12.2.8.8.5 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.2.8.8.6 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028

12.3.1 Overview

12.3.2 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.3 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.4 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.5 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.6 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.7 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Country (2022 & 2028)

12.3.8.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.1.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.1.2 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.1.3 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.1.4 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.1.5 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.1.6 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.2.1 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.2.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.2.3 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.2.4 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.2.5 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.2.6 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.3.1 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.3.2 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.3.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.3.4 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.3.5 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.3.6 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.4.1 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.4.2 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.4.3 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.4.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.4.5 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.4.6 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.5.1 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.5.2 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.5.3 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.5.4 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.5.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.5.6 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.6 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.6.1 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.6.2 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.6.3 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.6.4 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.6.5 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.6.6 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.7 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.7.1 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.7.2 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.7.3 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.7.4 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.7.5 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.7.6 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.8 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.8.1 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.8.2 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.8.3 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.8.4 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.8.5 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.8.6 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.9 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.9.1 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.9.2 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.9.3 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.9.4 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.9.5 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.9.6 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.10 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.10.1 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.10.2 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.10.3 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.10.4 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.10.5 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.10.6 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.11 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.11.1 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.11.2 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.11.3 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.11.4 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.11.5 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.11.6 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.3.8.12 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

12.3.8.12.1 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

12.3.8.12.2 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

12.3.8.12.3 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

12.3.8.12.4 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

12.3.8.12.5 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

12.3.8.12.6 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

12.4 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast To 2028

12.4.1 Overview

12.4.2 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.3 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.4 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.5 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.6 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.7 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

12.4.8.1 UAE: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.1.1 Overview

12.4.8.1.2 UAE: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.1.3 UAE: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.1.4 UAE: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.1.5 UAE: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.1.6 UAE: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.1.7 UAE: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.2 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.2.1 Overview

12.4.8.2.2 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.2.3 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.2.4 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.2.5 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.2.6 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.2.7 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.3 South Africa: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.3.1 Overview

12.4.8.3.2 South Africa: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.3.3 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.3.4 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.3.5 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.3.6 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.3.7 South Africa: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.4 Iran: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.4.1 Overview

12.4.8.4.2 Iran: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.4.3 Iran: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.4.4 Iran: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.4.5 Iran: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.4.6 Iran: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.4.7 Iran: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.5 Turkey: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.5.1 Overview

12.4.8.5.2 Turkey: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.5.3 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.5.4 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.5.5 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.5.6 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.5.7 Turkey: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.6 Kuwait: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.6.1 Overview

12.4.8.6.2 Kuwait: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.6.3 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.6.4 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.6.5 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.6.6 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.6.7 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.7 Bahrain: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.7.1 Overview

12.4.8.7.2 Bahrain: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.7.3 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.7.4 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.7.5 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.7.6 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.7.7 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.8 Egypt: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.8.1 Overview

12.4.8.8.2 Egypt: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.8.3 Egypt: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.8.4 Egypt: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.8.5 Egypt: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.8.6 Egypt: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.8.7 Egypt: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.4.8.9 Rest of Middle the East and Africa: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.9.1 Overview

12.4.8.9.2 Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

12.4.8.9.3 Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019–2028 (US$ Million)

12.4.8.9.4 Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019–2028 (US$ Million)

12.4.8.9.5 Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019–2028 (US$ Million)

12.4.8.9.6 Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019–2028 (US$ Million)

12.4.8.9.7 Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019–2028 (US$ Million)

12.5 South and Central America Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028

12.5.1 Overview

12.5.2 South & Central America Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.3 South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.4 South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.5 South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.6 South & Central America: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.7 South & Central America: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8 South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Country (%)

12.5.8.1 Argentina Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.5.8.1.1 Overview

12.5.8.1.2 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.1.3 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.1.4 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.1.5 Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.1.6 Argentina: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.1.7 Argentina: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8.2 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.5.8.2.1 Overview

12.5.8.2.2 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.2.3 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.2.4 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.2.5 Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.2.6 Brazil: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.2.7 Brazil: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8.3 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.5.8.3.1 Overview

12.5.8.3.2 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.3.3 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.3.4 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.3.5 Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.3.6 Chile: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.3.7 Chile: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8.4 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.5.8.4.1 Overview

12.5.8.4.2 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.4.3 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.4.4 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.4.5 Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.4.6 Guatemala: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.4.7 Guatemala: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8.5 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.5.8.5.1 Overview

12.5.8.5.2 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.5.3 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.5.4 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.5.5 Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.5.6 Peru: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.5.7 Peru: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8.6 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

12.5.8.6.1 Overview

12.5.8.6.2 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.6.3 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.6.4 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.6.5 Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.6.6 Colombia: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.6.7 Colombia: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

12.5.8.7 Rest of South and Central America: Human Papillomavirus (HPV) Vaccine Market– Revenue and Forecast to 2028 (USD Million)

12.5.8.7.1 Overview

12.5.8.7.2 Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

12.5.8.7.3 Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

12.5.8.7.4 Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

12.5.8.7.5 Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

12.5.8.7.6 Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

12.5.8.7.7 Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

13. Impact Of COVID-19 Pandemic on Human Papillomavirus (HPV) Vaccine Market

13.1 North America: Impact Assessment of COVID-19 Pandemic

13.2 Europe: Impact Assessment of COVID-19 Pandemic

13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

13.5 South & Central America: Impact Assessment of COVID-19 Pandemic

14. Human Papillomavirus (HPV) Vaccine Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the HPV Vaccines Market, 2021-2028

14.3 Inorganic Growth Strategies

14.3.1 Overview

14.4 Organic Growth Strategies

14.4.1 Overview

15. Company Profiles

15.1 Merck & Co., Inc.

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 GlaxoSmithKline plc.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 INNOVAX

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 Serum Institute of India Pvt. Ltd

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Walvax Biotechnology Co., Ltd.

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 INOVIO Pharmaceuticals

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 Vaccitech

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 2A Pharma

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 ChengDu Institute of Biological Products Co., Ltd.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 Sanofi

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

15.11 R-Pharm

15.11.1 Key Facts

15.11.2 Business Description

15.11.3 Products and Services

15.11.4 Financial Overview

15.11.5 SWOT Analysis

15.11.6 Key Developments

15.12 Shanghai Bowei

15.12.1 Key Facts

15.12.2 Business Description

15.12.3 Products and Services

15.12.4 Financial Overview

15.12.5 SWOT Analysis

15.12.6 Key Developments

15.13 BioLeaders

15.13.1 Key Facts

15.13.2 Business Description

15.13.3 Products and Services

15.13.4 Financial Overview

15.13.5 SWOT Analysis

15.13.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (USD Million)

Table 3. North America Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (USD Million)

Table 4. North America Human Papillomavirus (HPV) Vaccine Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 8. US Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 9. US Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Europe: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 23. Europe: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 24. Europe: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 26. Germany: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 29. Germany: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 30. Germany: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. France: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 33. France: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 34. France: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 35. France: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 36. UK: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 37. UK: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 38. UK: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 39. UK: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 40. UK: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 41. Italy: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 42. Italy: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 43. Italy: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 44. Italy: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 45. Italy: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 46. Spain: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 47. Spain: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 48. Spain: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 49. Spain: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 50. Spain: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 51. Russia: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 52. Russia: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 53. Russia: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 54. Russia: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 55. Russia: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 56. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 57. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 58. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 59. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 60. Belarus: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 61. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 62. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 63. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 64. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 65. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 66. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 67. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 68. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 69. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 70. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 71. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 72. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 73. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 74. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 75. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 76. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 77. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 78. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 79. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 80. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 81. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 82. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 83. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 84. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 85. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 86. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 87. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 88. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 89. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 90. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 91. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 92. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 93. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 94. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 95. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 96. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 97. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 98. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 99. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 100. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 101. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 102. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 103. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 104. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 105. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 106. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 107. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 108. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 109. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 110. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 111. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 112. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 113. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 114. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 115. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 116. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 117. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 118. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 119. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 120. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 121. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 122. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 123. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 124. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 125. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 126. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)

Table 127. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)

Table 128. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)

Table 129. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)

Table 130. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)

Table 131. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 132. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (USD Million)

Table 133. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (USD Million)

Table 134. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 135. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 136. UAE Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 137. UAE Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 138. UAE Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 139. UAE Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 140. UAE Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 141. Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 142. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 143. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 144. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 145. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 146. South Africa: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 147. South Africa Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 148. South Africa Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 149. South Africa Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 150. South Africa Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 151. Iran: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 152. Iran Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 153. Iran Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 154. Iran Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 155. Iran Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 156. Turkey: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 157. Turkey Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 158. Turkey Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 159. Turkey Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 160. Turkey Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 161. Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 162. Kuwait Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 163. Kuwait Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 164. Kuwait Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 165. Kuwait Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 166. Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 167. Bahrain Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 168. Bahrain Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 169. Bahrain Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 170. Bahrain Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 171. Egypt: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 172. Egypt Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 173. Egypt Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 174. Egypt Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 175. Egypt Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 176. Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 177. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Dosage– Revenue and Forecast to 2028 (US$ Million)

Table 178. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Age– Revenue and Forecast to 2028 (US$ Million)

Table 179. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 180. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 181. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million).

Table 182. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 183. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 184. South & Central America: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 185. South & Central America: Human Papillomavirus (HPV) Vaccine Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 186. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 187. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 188. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 189. Argentina: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 190. Argentina: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 191. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 192. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 193. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 194. Brazil: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 195. Brazil: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 196. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 197. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 198. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 199. Chile: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 200. Chile: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 201. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 202. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 203. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 204. Guatemala: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 205. Guatemala: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 206. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 207. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 208. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 209. Peru: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 210. Peru: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 211. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 212. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 213. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 214. Colombia: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 215. Colombia: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 216. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 217. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)

Table 218. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)

Table 219. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 220. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 221. Recent Inorganic Growth Strategies in the HPV Vaccines Market

Table 222. Recent Organic Growth Strategies in the HPV Vaccines Market

Table 223. Glossary of Terms

LIST OF FIGURES

Figure 1. Human Papillomavirus (HPV) Vaccines Market Segmentation

Figure 2. Human Papillomavirus (HPV) Vaccines Market, By Region

Figure 3. Global Human Papillomavirus (HPV) Vaccine Market Overview

Figure 4. 9-Valent HPV Vaccine Segment Held Largest Share of Type Segment in Human Papillomavirus (HPV) Vaccines Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Human Papillomavirus (HPV) Vaccine Market, by Geography (US$ Million)

Figure 7. Global Human Papillomavirus (HPV) Vaccine Market - Leading Country Markets (US$ Million)

Figure 8. Global Human Papillomavirus (HPV) Vaccine Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East and Africa: PEST Analysis

Figure 13. South And Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Global Human Papillomavirus (HPV) Vaccines Market Impact Analysis of Driver and Restraints

Figure 16. Global Human Papillomavirus (HPV) Vaccine Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 17. Global HPV Vaccines Market – By Geography Forecasts And Analysis – 2022- 2028

Figure 18. Global Human Papillomavirus (HPV) Vaccine Market – Market Potential Analysis, By Region

Figure 19. Global Human Papillomavirus (HPV) Vaccine Market – Pricing Analysis, By Region

Figure 20. Global Human Papillomavirus (HPV) Vaccine Market – Patent Status

Figure 21. Global HPV Vaccines market – Growth Strategy Analysis

Figure 22. By Type: Market Analysis and Forecast 2022 and 2028 (%)

Figure 23. 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)

Figure 27. 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)

Figure 30. 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)

Figure 33. HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)

Figure 36. Doctor Office Market Revenue and Forecast to 2028 (US$ Million)

Figure 37. Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)

Figure 38. School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)

Figure 39. Health Departments Market Revenue and Forecast to 2028 (US$ Million)

Figure 40. Hospitals Market Revenue and Forecast to 2028 (US$ Million)

Figure 41. Others Market Revenue and Forecast to 2028 (US$ Million)

Figure 42. North America: Human Papillomavirus (HPV) Vaccine Market, by Key Country – Revenue (2022) (US$ Million)

Figure 43. North America Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 44. North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

Figure 45. US: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Canada: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Mexico: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Europe: Human Papillomavirus (HPV) Vaccine Market, by Key Country – Revenue (2022) (US$ Million)

Figure 49. Europe: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 50. Europe: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

Figure 51. Germany: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 52. France: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 53. UK: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. Italy: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. Spain: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56. Russia Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 57. Belarus: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 58. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Asia Pacific Human Papillomavirus (HPV) Vaccines Market Overview, by Country (2022)

Figure 60. Asia Pacific Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 61. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Country (2022 & 2028)

Figure 62. Japan Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 63. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 64. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 65. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 66. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 67. New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 68. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 69. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 70. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 71. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 72. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Figure 73. Rest Of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 74. Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Key Country – Revenue (2022) (US$ Million)

Figure 75. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)

Figure 76. Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)

Figure 77. UAE: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 78. Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 79. South Africa: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 80. Iran: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 81. Turkey: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 82. Kuwait: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 83. Bahrain: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 84. Egypt: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 85. Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

Figure 86. South & Central America Human Papillomavirus (HPV) Vaccine Market Overview, by Country (2022)

Figure 87. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 88. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Country (%)

Figure 89. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 90. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 91. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 92. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 93. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 94. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 95. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)

Figure 96. Impact of COVID-19 Pandemic in North American Country Markets

Figure 97. Impact of COVID-19 Pandemic in European Country Markets

Figure 98. Impact of COVID-19 Pandemic on Asia Pacific Country Markets

Figure 99. Impact of COVID-19 Pandemic on Middle East & African Countries

Figure 100. Impact of COVID-19 Pandemic on South & Central America Countries

Figure 101. Growth Strategies in the HPV Vaccines Market, 2021-2028

The List Of Companies - HPV Vaccines Market

  1. Merck & Co. In.
  2. GSK
  3. Serum Institute of India
  4. Walvax Biotechnologies
  5. Innova
  6. Vaccitech
  7. Innovio Pharmaceuticals
  8. Chengdu Institute of Biological Products Co., Ltd.
  9. Sanofi
  10. R-Pharm
  11. Shanghai Bowei
  12. Bioleaders
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human papillomavirus vaccine market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global human papillomavirus vaccine market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00029411
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount